
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Antibody-mediated inhibition of MICA and MICB shedding promotes NK cell–driven tumor immunity
Lucas Ferrari de Andrade, Rong En Tay, Deng Pan, et al.
Science (2018) Vol. 359, Iss. 6383, pp. 1537-1542
Open Access | Times Cited: 378
Lucas Ferrari de Andrade, Rong En Tay, Deng Pan, et al.
Science (2018) Vol. 359, Iss. 6383, pp. 1537-1542
Open Access | Times Cited: 378
Showing 1-25 of 378 citing articles:
The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications
Yuanyuan Zhang, Zemin Zhang
Cellular and Molecular Immunology (2020) Vol. 17, Iss. 8, pp. 807-821
Open Access | Times Cited: 1990
Yuanyuan Zhang, Zemin Zhang
Cellular and Molecular Immunology (2020) Vol. 17, Iss. 8, pp. 807-821
Open Access | Times Cited: 1990
NK cells for cancer immunotherapy
Noriko Shimasaki, Amit Jain, Dario Campana
Nature Reviews Drug Discovery (2020) Vol. 19, Iss. 3, pp. 200-218
Closed Access | Times Cited: 959
Noriko Shimasaki, Amit Jain, Dario Campana
Nature Reviews Drug Discovery (2020) Vol. 19, Iss. 3, pp. 200-218
Closed Access | Times Cited: 959
Natural Killer Cells: Development, Maturation, and Clinical Utilization
Alex M. Abel, Chao Yang, Monica S. Thakar, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 935
Alex M. Abel, Chao Yang, Monica S. Thakar, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 935
Exploring the NK cell platform for cancer immunotherapy
Jacob A. Myers, Jeffrey S. Miller
Nature Reviews Clinical Oncology (2020) Vol. 18, Iss. 2, pp. 85-100
Open Access | Times Cited: 908
Jacob A. Myers, Jeffrey S. Miller
Nature Reviews Clinical Oncology (2020) Vol. 18, Iss. 2, pp. 85-100
Open Access | Times Cited: 908
Natural killer cells and other innate lymphoid cells in cancer
Laura Chiossone, Pierre‐Yves Dumas, Margaux Vienne, et al.
Nature reviews. Immunology (2018) Vol. 18, Iss. 11, pp. 671-688
Closed Access | Times Cited: 856
Laura Chiossone, Pierre‐Yves Dumas, Margaux Vienne, et al.
Nature reviews. Immunology (2018) Vol. 18, Iss. 11, pp. 671-688
Closed Access | Times Cited: 856
Radiotherapy induces responses of lung cancer to CTLA-4 blockade
Silvia C. Formenti, Nils-Petter Rudqvist, Encouse B. Golden, et al.
Nature Medicine (2018) Vol. 24, Iss. 12, pp. 1845-1851
Open Access | Times Cited: 756
Silvia C. Formenti, Nils-Petter Rudqvist, Encouse B. Golden, et al.
Nature Medicine (2018) Vol. 24, Iss. 12, pp. 1845-1851
Open Access | Times Cited: 756
Cancer immunotherapy: Pros, cons and beyond
Shuzhen Tan, Dongpei Li, Xiao Zhu
Biomedicine & Pharmacotherapy (2020) Vol. 124, pp. 109821-109821
Open Access | Times Cited: 543
Shuzhen Tan, Dongpei Li, Xiao Zhu
Biomedicine & Pharmacotherapy (2020) Vol. 124, pp. 109821-109821
Open Access | Times Cited: 543
The hallmarks of successful anticancer immunotherapy
Lorenzo Galluzzi, Timothy A. Chan, Guido Kroemer, et al.
Science Translational Medicine (2018) Vol. 10, Iss. 459
Open Access | Times Cited: 491
Lorenzo Galluzzi, Timothy A. Chan, Guido Kroemer, et al.
Science Translational Medicine (2018) Vol. 10, Iss. 459
Open Access | Times Cited: 491
The cancer–natural killer cell immunity cycle
Nicholas D. Huntington, Joseph Cursons, Jai Rautela
Nature reviews. Cancer (2020) Vol. 20, Iss. 8, pp. 437-454
Closed Access | Times Cited: 442
Nicholas D. Huntington, Joseph Cursons, Jai Rautela
Nature reviews. Cancer (2020) Vol. 20, Iss. 8, pp. 437-454
Closed Access | Times Cited: 442
The NK cell–cancer cycle: advances and new challenges in NK cell–based immunotherapies
Tobias Bald, Matthew F. Krummel, Mark J. Smyth, et al.
Nature Immunology (2020) Vol. 21, Iss. 8, pp. 835-847
Open Access | Times Cited: 370
Tobias Bald, Matthew F. Krummel, Mark J. Smyth, et al.
Nature Immunology (2020) Vol. 21, Iss. 8, pp. 835-847
Open Access | Times Cited: 370
Cancer Immunotherapy Based on Natural Killer Cells: Current Progress and New Opportunities
Weilei Hu, Guosheng Wang, Dongsheng Huang, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 360
Weilei Hu, Guosheng Wang, Dongsheng Huang, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 360
Tumor-Infiltrating Natural Killer Cells
Beatriz Cózar, Marco Greppi, Sabrina Carpentier, et al.
Cancer Discovery (2020) Vol. 11, Iss. 1, pp. 34-44
Open Access | Times Cited: 346
Beatriz Cózar, Marco Greppi, Sabrina Carpentier, et al.
Cancer Discovery (2020) Vol. 11, Iss. 1, pp. 34-44
Open Access | Times Cited: 346
NK cell–mediated cytotoxicity contributes to tumor control by a cytostatic drug combination
Marcus Ruscetti, Josef Leibold, Matthew J. Bott, et al.
Science (2018) Vol. 362, Iss. 6421, pp. 1416-1422
Open Access | Times Cited: 341
Marcus Ruscetti, Josef Leibold, Matthew J. Bott, et al.
Science (2018) Vol. 362, Iss. 6421, pp. 1416-1422
Open Access | Times Cited: 341
Roles of natural killer cells in immunity to cancer, and applications to immunotherapy
Natalie K. Wolf, Djem Kissiov, David H. Raulet
Nature reviews. Immunology (2022) Vol. 23, Iss. 2, pp. 90-105
Closed Access | Times Cited: 299
Natalie K. Wolf, Djem Kissiov, David H. Raulet
Nature reviews. Immunology (2022) Vol. 23, Iss. 2, pp. 90-105
Closed Access | Times Cited: 299
The Emergence of Natural Killer Cells as a Major Target in Cancer Immunotherapy
Fernando Souza-Fonseca-Guimarães, Joseph Cursons, Nicholas D. Huntington
Trends in Immunology (2019) Vol. 40, Iss. 2, pp. 142-158
Closed Access | Times Cited: 257
Fernando Souza-Fonseca-Guimarães, Joseph Cursons, Nicholas D. Huntington
Trends in Immunology (2019) Vol. 40, Iss. 2, pp. 142-158
Closed Access | Times Cited: 257
The Rebirth of Matrix Metalloproteinase Inhibitors: Moving Beyond the Dogma
Gregg B. Fields
Cells (2019) Vol. 8, Iss. 9, pp. 984-984
Open Access | Times Cited: 257
Gregg B. Fields
Cells (2019) Vol. 8, Iss. 9, pp. 984-984
Open Access | Times Cited: 257
Immunobiology and immunotherapy of HCC: spotlight on innate and innate-like immune cells
Benjamin Ruf, Bernd Heinrich, Tim F. Greten
Cellular and Molecular Immunology (2020) Vol. 18, Iss. 1, pp. 112-127
Open Access | Times Cited: 233
Benjamin Ruf, Bernd Heinrich, Tim F. Greten
Cellular and Molecular Immunology (2020) Vol. 18, Iss. 1, pp. 112-127
Open Access | Times Cited: 233
Cocultures of human colorectal tumor spheroids with immune cells reveal the therapeutic potential of MICA/B and NKG2A targeting for cancer treatment
Tristan Courau, Julie Bonnereau, Justine Chicoteau, et al.
Journal for ImmunoTherapy of Cancer (2019) Vol. 7, Iss. 1
Open Access | Times Cited: 202
Tristan Courau, Julie Bonnereau, Justine Chicoteau, et al.
Journal for ImmunoTherapy of Cancer (2019) Vol. 7, Iss. 1
Open Access | Times Cited: 202
Killers 2.0: NK cell therapies at the forefront of cancer control
Jonathan J. Hodgins, S. Khan, Maria M. Park, et al.
Journal of Clinical Investigation (2019) Vol. 129, Iss. 9, pp. 3499-3510
Open Access | Times Cited: 183
Jonathan J. Hodgins, S. Khan, Maria M. Park, et al.
Journal of Clinical Investigation (2019) Vol. 129, Iss. 9, pp. 3499-3510
Open Access | Times Cited: 183
An expanded universe of cancer targets
William C. Hahn, Joel S. Bader, Theodore P. Braun, et al.
Cell (2021) Vol. 184, Iss. 5, pp. 1142-1155
Open Access | Times Cited: 179
William C. Hahn, Joel S. Bader, Theodore P. Braun, et al.
Cell (2021) Vol. 184, Iss. 5, pp. 1142-1155
Open Access | Times Cited: 179
Mechanisms of immune activation and regulation: lessons from melanoma
Shelly Kalaora, Adi Nagler, Jennifer A. Wargo, et al.
Nature reviews. Cancer (2022) Vol. 22, Iss. 4, pp. 195-207
Closed Access | Times Cited: 166
Shelly Kalaora, Adi Nagler, Jennifer A. Wargo, et al.
Nature reviews. Cancer (2022) Vol. 22, Iss. 4, pp. 195-207
Closed Access | Times Cited: 166
The IRE1 endoplasmic reticulum stress sensor activates natural killer cell immunity in part by regulating c-Myc
Han Dong, Nicholas M. Adams, Yichi Xu, et al.
Nature Immunology (2019) Vol. 20, Iss. 7, pp. 865-878
Open Access | Times Cited: 148
Han Dong, Nicholas M. Adams, Yichi Xu, et al.
Nature Immunology (2019) Vol. 20, Iss. 7, pp. 865-878
Open Access | Times Cited: 148
Nanomedicine‐Based Immunotherapy for the Treatment of Cancer Metastasis
Pengcheng Zhang, Yihui Zhai, Ying Cai, et al.
Advanced Materials (2019) Vol. 31, Iss. 49
Closed Access | Times Cited: 148
Pengcheng Zhang, Yihui Zhai, Ying Cai, et al.
Advanced Materials (2019) Vol. 31, Iss. 49
Closed Access | Times Cited: 148
Harnessing natural killer cells for cancer immunotherapy: dispatching the first responders
Nicholas A. Maskalenko, Dmitry Zhigarev, Kerry S. Campbell
Nature Reviews Drug Discovery (2022) Vol. 21, Iss. 8, pp. 559-577
Open Access | Times Cited: 135
Nicholas A. Maskalenko, Dmitry Zhigarev, Kerry S. Campbell
Nature Reviews Drug Discovery (2022) Vol. 21, Iss. 8, pp. 559-577
Open Access | Times Cited: 135
Human NK cells, their receptors and function
Linda Quatrini, Mariella Della Chiesa, Simona Sivori, et al.
European Journal of Immunology (2021) Vol. 51, Iss. 7, pp. 1566-1579
Open Access | Times Cited: 122
Linda Quatrini, Mariella Della Chiesa, Simona Sivori, et al.
European Journal of Immunology (2021) Vol. 51, Iss. 7, pp. 1566-1579
Open Access | Times Cited: 122